If only, there was a way for investors and corporations to understand what motivates people to buy and sell stocks. If only, the brain could signal when certain stocks like Enron or Tyco were not the viable stocks they were touted to be. With the advancements in neurology, scientists may discover what motivates buying, selling and holding behavior.

A novel science is exploring the link between the brain and personal financial behavior. The new field is referred to as neuro- economics. It seeks to demystify the biology underlying economic behavior. Across the nation, research trials and universities are probing cerebral cortexes for the connection between the brain and investing decisions.

Researchers are trying to learn how the neural networks impact buying behavior. From buying to selling, the study is evaluating the way humans splurge and save. The studies are evaluating how the financial mind works. Scientists are working to demystify how neural circuits formulate the decision process. “We have started looking for pieces of economic theory in the brain,” states New York University neuroscientist Paul Glimcher.

It seems the FDA can’t quite make up it’s mind about Pfizer’s mega-drug, Celebrex. Is it harmful, or is it safe?

In an unusual move that reflects serious concerns about the new results, the agency asked the company to suspend its use of direct-to-consumer advertising and alter its marketing to doctors, as regulators and the company examine the data from the National Institutes of Health trial. The commitment was “open- ended,” said John Jenkins, director of the FDA’s office of new drugs.

More on CNN Money: FDA Asks Pfizer to Pull Back Marketing of Celebrex

Welcome to Streetsters.com. We cover the latest financial and business news coming out of Wall Street, focusing on fresh news, advice and tips relevant for today’s investors and businesspeople.

Check back regularly, or subscribe to our RSS feed to keep up on news from the Street.